Biosimilar Interchangeability Guidelines on Track for 2016 Release, Woodcock Says

Drug Industry Daily
A A
The FDA will release biosimilar interchangeability guidelines on schedule by the end of the year, CDER Director Janet Woodcock confirmed yesterday.

To View This Article:

Login

Subscribe To Drug Industry Daily